Inhibrx Biosciences Insider Moves Spark Confidence, Caution – What’s Next?
Inhibrx Biosciences insider buys, institutional sales, and a 59 % price jump raise questions about confidence and valuation in this biotech firm’s future.
3 minutes to read
Inhibrx Biosciences Inc